MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Predictors of refractory impulse control disorder to dopamine agonists substitution therapy in Parkinson’s disease patients

JY. Lee, J-H. Choi, B. Jeon, J. Cho (Seoul, Republic of Korea)

Meeting: 2019 International Congress

Abstract Number: 1584

Keywords: Dopamine agonists, Obsessive-compulsive behavior/disorder, Parkinsonism

Session Information

Date: Wednesday, September 25, 2019

Session Title: Non-Motor Symptoms

Session Time: 1:15pm-2:45pm

Location: Agora 3 West, Level 3

Objective: This study was aimed to investigate a predictive factor of refractory impulse control disorder (ICD) in patients with Parkinson’s disease (PD) who participated in a multicenter intervention trial for ICD (REIN-PD trial).

Background: Although dopamine agonist is a significant contributor to ICD development, dopamine agonist substitution with levodopa could not improve aberrant behaviors in some PD patients. If we could predict intractable ICD, we could make a therapeutic plan with a multidisciplinary approach to these individuals in advance.

Method: We conducted a case-control study using the REIN-PD database. Poor response (PR) group was defined as those who showed paradoxical increases in modified Minnesota Impulsive Disorders Interview (mMIDI) after substituting dopamine agonists with levodopa formulations in REIN-PD trial. We analyzed baseline neuropsychiatric traits of PR group in comparison to good response (GR) group to identify potential risk trait that can predict PR at 12 weeks after intervention. An extended analysis was carried out in the non-PR total REIN-PD ICD (TOTAL) group that included all dropped-out cases as well as the GR group. Finally, Receiver Operating Characteristic (ROC) curve analysis was performed to evaluate the predictive efficacy of the potential risk trait for refractory ICD.

Results: Among the 38 patients who completed dopamine agonist replacement in REIN-PD trial, we identified 15 (39.5%) PR and 20 GR patients. Baseline demographics, ICD severity, PD severity, and dopaminergic medications were indifferent between the PR and GR groups. However, PR group had distinctively high scores compared to GR group in the baseline State-Trait Anger Expression Inventory (K-STAXI) and the Obsessive-Compulsive Inventory-Revised (K-OCI-R) (36.3±11.3 vs. 27.7±5.2 and 28.9±12.8 vs. 17.8±14.2, p = 0.007 and 0.009, respectively). The baseline K-OCI-R in PR group was also significantly high when it was compared with that in TOTAL group (N=35, intention-to-treat analysis; 28.9±12.8 vs. 18.1±13.9, p = 0.009). In the ROC curve analysis, the baseline K-OCI-R showed the highest area under the curve [AUC = 0.735 (0.591-0.850)] with optimal cut-off score 22/72 in discriminating the PR from the TOTAL group.

Conclusion: Obsessive-compulsiveness may predict a poor response to dopamine agonist substitution therapy in PD patients with ICD.

References: Lee JY, Jeon B, Koh SB, Yoon WT, Lee HW, Kwon OD, Kim JW, Kim JM, Ma HI, Kim HT, Baik JS, Cho J; (REIN-PD Investigators). Behavioral and trait changes in parkinsonian patients with impulse control disorder after switching from dopamine agonist to levodopa therapy: results of REIN-PD trial. J Neurol Neurosurg Psychiatry. 2019 Jan;90(1):30-37.

To cite this abstract in AMA style:

JY. Lee, J-H. Choi, B. Jeon, J. Cho. Predictors of refractory impulse control disorder to dopamine agonists substitution therapy in Parkinson’s disease patients [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/predictors-of-refractory-impulse-control-disorder-to-dopamine-agonists-substitution-therapy-in-parkinsons-disease-patients/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/predictors-of-refractory-impulse-control-disorder-to-dopamine-agonists-substitution-therapy-in-parkinsons-disease-patients/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley